HSBC Holdings
LAB icon

HSBC Holdings’s Standard BioTools LAB Stock Holding History

HSBC Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45,685
Closed -$59.2K – 3060
2025
Q3 		$59.2K Sell
45,685
-10,492
-19% -$13.7K ﹤0.01% 2638
2025
Q2 		$67.1K Sell
56,177
-23,595
-30% -$26.2K ﹤0.01% 2906
2025
Q1 		$85.8K Sell
79,772
-225
-0.3% -$316 ﹤0.01% 2841
2024
Q4 		$139K Sell
79,997
-2,613
-3% -$4.87K ﹤0.01% 2818
2024
Q3 		$157K Buy
82,610
+33,609
+69% +$65.8K ﹤0.01% 2700
2024
Q2 		$88.9K Hold
49,001
– – ﹤0.01% 2754
2024
Q1 		$133K Buy
+49,001
New +$118K ﹤0.01% 2780
2019
Q3 		– Sell
-107,183
Closed -$1.32M – 3109
2019
Q2 		$1.32M Buy
+107,183
New +$1.37M ﹤0.01% 1677

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

HSBC Holdings's LAB Position: Q4 2025 in Review

HSBC Holdings sold out of Standard BioTools (LAB) in Q4 2025, closing a stake of 45,685 shares — an estimated $59.2K sold.

HSBC Holdings first reported a position in LAB in Q2 2019 and held it in 8 quarters. The position peaked at $1.32M in Q2 2019. 159 funds tracked by Wall St. Rank hold LAB as of Q4 2025.

  • HSBC Holdings reported no remaining Standard BioTools position as of Q4 2025 after selling out during the quarter.
  • HSBC Holdings sold 45,685 Standard BioTools shares in Q4 2025, an estimated $59.2K.
  • HSBC Holdings first reported a position in Standard BioTools in Q2 2019 and held it in 8 quarters.
  • HSBC Holdings's Standard BioTools position peaked at $1.32M in Q2 2019.
  • 159 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2025.

Based on HSBC Holdings's 13F filing for Q4 2025, filed 6 Mar 2026.